These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7638133)

  • 1. [Substitutive hormonal treatment of menopause. Effects on lipoprotein metabolism].
    Turpin G; Bruckert E; Dairou F
    Presse Med; 1995 May; 24(19):905-9. PubMed ID: 7638133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine control of plasma lipoprotein metabolism: effects of gonadal steroids.
    Crook D; Seed M
    Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):851-75. PubMed ID: 2082909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
    Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N; Devaraj SN; Devaraj H
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Very low density lipoproteins and subclasses of intermediate density lipoproteins in postmenopausal women].
    Berg G; Halperín H; Siseles N; Wikinski R
    Medicina (B Aires); 1996; 56(5 Pt 1):479-86. PubMed ID: 9239883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
    Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females.
    Schaefer EJ; Foster DM; Zech LA; Lindgren FT; Brewer HB; Levy RI
    J Clin Endocrinol Metab; 1983 Aug; 57(2):262-7. PubMed ID: 6408108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC
    Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
    N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of hormone replacement therapy during menopause in the cardiovascular prevention].
    Turpin G
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):177-80. PubMed ID: 8024230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and lipoprotein metabolism.
    Tikkanen MJ; Nikkilä EA
    J Reprod Med; 1986 Sep; 31(9 Suppl):898-905. PubMed ID: 3772909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the profile of lipoprotein subfractions associated with hormone replacement therapy.
    da Costa Vieira JL; Gomes ME; Almeida AB; Moriguchi EH
    Arq Bras Cardiol; 2001 Mar; 76(3):177-88. PubMed ID: 11262568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estrogen replacement therapy and cardiovascular disease in postmenopausal women. II. Mechanisms of action of estrogens].
    Sitruk-Ware R
    Presse Med; 1990 Sep; 19(29):1364-7. PubMed ID: 2146610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.